EN
es 
jp 
ko 
fr 
de 
it 
ru 
pt 
th 
ar 
ms 
As the Food Ingredients China 2026 (FIC 2026) approaches, the themes emerging from conference forums reveal a clear signal about where the industry is heading. Topics such as nutrient innovation, bio-based liposome construction, multi-effect delivery, and precision nutrition are appearing again and again. Together, they point to a broader shift: the nutraceutical industry is moving from ingredient competition toward delivery efficiency competition.
Over the past decade, most product innovation in supplements has been driven by the discovery of new active ingredients and the accumulation of clinical or functional research. New compounds, new claims, and new marketing concepts helped drive rapid market growth. But as the market matures, many ingredients have already become widely available. As a result, product differentiation based solely on ingredients has become increasingly difficult.
At the same time, consumer awareness is evolving. Today’s buyers—especially informed supplement consumers—are starting to ask a more practical question: can the body actually absorb and use the ingredient effectively? This shift in mindset is pushing the industry to look beyond ingredient lists and toward the science of delivery. As a result, nutraceutical delivery systems are becoming a central focus in product development.
From a broader perspective, the development of the nutraceutical industry can be viewed in three phases. The first phase was the ingredient discovery era, where innovation was driven by the introduction of new compounds. The second phase was the efficacy validation era, where brands relied on scientific studies and functional data to support product claims. Today, the industry is entering a third phase—the delivery efficiency era—where improving absorption and utilization has become a key competitive factor.
Among the emerging solutions, liposomal delivery technology has quickly become one of the most discussed approaches in supplement formulation. Liposomes are microscopic vesicles composed of phospholipid bilayers that can encapsulate active ingredients. Their value lies in the ability to enhance stability and improve bioavailability in supplements without altering the chemical structure of the active compound itself.
In recent years, liposome technology has gained significant attention across multiple health categories, including energy metabolism, healthy aging, cardiovascular support, and cellular health. Because liposomes can help protect sensitive compounds and improve delivery efficiency, they are increasingly used in the development of advanced liposome nutraceuticals.
As adoption grows, the conversation within the industry is also evolving. The question is no longer simply whether a product should use liposomes. Instead, the focus has shifted toward how liposome technology is designed and applied within a formulation. Discussions around functional regulation, multi-component delivery, and precision nutrition reflect this next stage of development.
The technology trends highlighted at FIC 2026 may represent only a snapshot of a larger transformation underway. But one thing is becoming increasingly clear: in the future of functional nutrition, delivery technology will not just be a value-added feature—it may become a defining factor in product differentiation.
Source: Compiled from industry reports by Grand View Research, MarketsandMarkets, Nutrition Business Journal (NBJ)
